Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 17 Schemes (13.56%)
Foreign Institutions
Held by 33 Foreign Institutions (20.12%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
54 Million
(Quarterly Results - Dec 2025)
Net Profit:
58 Million
Pharmaceuticals & Biotechnology
USD 60 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
2.01
-999,999.00%
-3.27






